{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:49:10Z","timestamp":1765486150688,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13756-017-0269-x","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T13:52:34Z","timestamp":1510753954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-Candida activity of antimicrobial impregnated central venous catheters"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-9769","authenticated-orcid":false,"given":"L.","family":"Cobrado","sequence":"first","affiliation":[]},{"given":"A.","family":"Silva-Dias","sequence":"additional","affiliation":[]},{"given":"M. M.","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"A.","family":"Rodrigues","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"unstructured":"Centers for Disease Control and Prevention, Bloodstream infection event (Central Line-Associated Bloodstream Infection and non-central line-associated Bloodstream Infection), January 2017, \nhttps:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/4psc_clabscurrent.pdf\n\n.","key":"269_CR1"},{"unstructured":"CDC National and State Healthcare-Associated Infections Progress Report, March 2014, \nhttp:\/\/www.cdc.gov\/HAI\/progress-report\/hai-progress-report.pdf\n\n.","key":"269_CR2"},{"unstructured":"ECDC Suveillance Report, Annual epidemiological report, Antimicrobial resistance and healthcare-associated infections, 2014, \nhttps:\/\/ecdc.europa.eu\/sites\/portal\/files\/media\/en\/publications\/Publications\/antimicrobial-resistance-annual-epidemiological-report.pdf\n\n.","key":"269_CR3"},{"key":"269_CR4","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Fridkin SK. Emerging infections program healthcare-associated I, antimicrobial use prevalence survey T. Survey of health care-associated infections. N Engl J Med. 2014;370:2542\u20133.","journal-title":"N Engl J Med"},{"key":"269_CR5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/jac\/dkn281","volume":"62","author":"I Raad","year":"2008","unstructured":"Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother. 2008;62:746\u201350.","journal-title":"J Antimicrob Chemother"},{"key":"269_CR6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/clinids\/20.6.1531","volume":"20","author":"RP Wenzel","year":"1995","unstructured":"Wenzel RP. Nosocomial Candidemia - risk-factors and attributable mortality. Clin Infect Dis. 1995;20:1531\u20134.","journal-title":"Clin Infect Dis"},{"key":"269_CR7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3201\/eid0702.010226","volume":"7","author":"RM Donlan","year":"2001","unstructured":"Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7:277\u201381.","journal-title":"Emerg Infect Dis"},{"key":"269_CR8","doi-asserted-by":"crossref","first-page":"e33818","DOI":"10.1371\/journal.pone.0033818","volume":"7","author":"CJ Ingham","year":"2012","unstructured":"Ingham CJ, Boonstra S, Levels S, de Lange M, Meis JF, Schneeberger PM. Rapid Susceptibility Testing and Microcolony Analysis of Candida spp. Cultured and Imaged on Porous Aluminum Oxide. Plos One. 2012;7:e33818.","journal-title":"Plos One"},{"key":"269_CR9","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00002480-200011000-00037","volume":"46","author":"RM Donlan","year":"2000","unstructured":"Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J. 2000;46:S47\u201352.","journal-title":"ASAIO J"},{"key":"269_CR10","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1128\/JCM.00403-07","volume":"45","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol. 2007;45:3522\u20138.","journal-title":"J Clin Microbiol"},{"key":"269_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/AAC.01079-10","volume":"55","author":"MA Pfaller","year":"2011","unstructured":"Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and Nosocomial isolates in the SENTRY antimicrobial surveillance program, 2008-2009. Antimicrob Agents Ch. 2011;55:561\u20136.","journal-title":"Antimicrob Agents Ch."},{"key":"269_CR12","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","volume":"149","author":"SB Wey","year":"1989","unstructured":"Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med. 1989;149:2349\u201353.","journal-title":"Arch Intern Med"},{"key":"269_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1128\/CMR.00027-10","volume":"24","author":"ER Sydnor","year":"2011","unstructured":"Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev. 2011;24:141\u201373.","journal-title":"Clin Microbiol Rev"},{"key":"269_CR14","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","volume":"48","author":"DL Horn","year":"2009","unstructured":"Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, et al. Epidemiology and outcomes of Candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695\u2013703.","journal-title":"Clin Infect Dis"},{"key":"269_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1099\/jmm.0.045054-0","volume":"62","author":"JCO Sardi","year":"2013","unstructured":"Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Giannini MJSM. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10\u201324.","journal-title":"J Med Microbiol"},{"key":"269_CR16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/13693780903580121","volume":"48","author":"GH Pereira","year":"2010","unstructured":"Pereira GH, Muller PR, Szeszs MW, Levin AS, Melhem MSC. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. Albicans Candida species. Med Mycol. 2010;48:839\u201342.","journal-title":"Med Mycol"},{"key":"269_CR17","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/cid\/cir257","volume":"52","author":"NP O'Grady","year":"2011","unstructured":"O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:e162\u201393.","journal-title":"Clin Infect Dis"},{"unstructured":"Arrow\u00ae International. Arrowgard Blue\u00ae Antimicrobial Catheter Technology Information \nhttp:\/\/www.teleflex.com\/usa\/product-areas\/vascular-access\/vascular -access-catheters\/arrow-ergopack-system\/safety-information\/arrowgard-blue-technology-information.pdf\n\n. Accessed 21 Aug 2017.","key":"269_CR18"},{"unstructured":"Cook\u00ae Medical. Spectrum\u00ae Minocycline\/rifampin catheter. \nhttps:\/\/www.cookmedical.com\/data\/resources\/6%20CC-BM-ABRMCAT-EN-201202.pdf\n\n. Accessed 21 Aug 2017.","key":"269_CR19"},{"key":"269_CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/46.1.45","volume":"46","author":"JM Schierholz","year":"2000","unstructured":"Schierholz JM, Fleck C, Beuth J, Pulverer G. The antimicrobial efficacy of a new central venous catheter with long-term broad-spectrum activity. J Antimicrob Chemother. 2000;46:45\u201350.","journal-title":"J Antimicrob Chemother"},{"key":"269_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/jhin.2002.1358","volume":"53","author":"R AFE","year":"2003","unstructured":"AFE R, Guttler K, Konig DP, Yucel N, Korenkov M, Schierholz JM. Pharmacokinetics of the antimicrobial agents rifampicin and miconazole released from a loaded central venous catheter. J Hosp Infect. 2003;53:129\u201335.","journal-title":"J Hosp Infect"},{"key":"269_CR22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.CCM.0000201404.05523.34","volume":"34","author":"D Fraenkel","year":"2006","unstructured":"Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware RA. Prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med. 2006;34:668\u201375.","journal-title":"Crit Care Med"},{"key":"269_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.sla.0000171874.29934.61","volume":"242","author":"RO Darouiche","year":"2005","unstructured":"Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ, Metzler MH, et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters - a randomized controlled trial. Ann Surg. 2005;242:193\u2013200.","journal-title":"Ann Surg"},{"key":"269_CR24","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00134-004-2378-2","volume":"30","author":"C Leon","year":"2004","unstructured":"Leon C, Ruiz-Santana S, Rello J, de la Torre MV, Valles J, Alvarez-Lerma F, et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med. 2004;30:1891\u20139.","journal-title":"Intensive Care Med"},{"key":"269_CR25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","volume":"3","author":"CG Pierce","year":"2008","unstructured":"Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E, Ramage G, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3:1494\u2013500.","journal-title":"Nat Protoc"},{"key":"269_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.7326\/0003-4819-132-5-200003070-00009","volume":"132","author":"LA Mermel","year":"2000","unstructured":"Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391\u2013402.","journal-title":"Ann Intern Med"},{"key":"269_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jama.281.3.261","volume":"281","author":"DL Veenstra","year":"1999","unstructured":"Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection - a meta-analysis. Jama-J Am Med Assoc. 1999;281:261\u20137.","journal-title":"Jama-J Am Med Assoc"},{"key":"269_CR28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00134-004-2221-9","volume":"30","author":"C Brun-Buisson","year":"2004","unstructured":"Brun-Buisson C, Doyon F, Sollet JP, Cochard JF, Cohen Y, Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intens Care Med. 2004;30:837\u201343.","journal-title":"Intens Care Med"},{"key":"269_CR29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00520-005-0812-9","volume":"13","author":"T Ostendorf","year":"2005","unstructured":"Ostendorf T, Meinhold A, Harter C, Salwender H, Egerer G, Geiss HK, et al. Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients - a double-blind, randomised, prospective, controlled trial. Support Care Cancer. 2005;13:993\u20131000.","journal-title":"Support Care Cancer"},{"key":"269_CR30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-143-8-200510180-00007","volume":"143","author":"ME Rupp","year":"2005","unstructured":"Rupp ME, Lisco SJ, Lipsett PA, Ped TM, Keating K, Civetta JM, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter - related infections - a randomized, controlled trial. Ann Intern Med. 2005;143:570\u201380.","journal-title":"Ann Intern Med"},{"key":"269_CR31","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00000542-199711000-00031","volume":"87","author":"T Oda","year":"1997","unstructured":"Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central nervous catheter. Anesthesiology. 1997;87:1242\u20134.","journal-title":"Anesthesiology"},{"key":"269_CR32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/bja\/87.2.306","volume":"87","author":"R Stephens","year":"2001","unstructured":"Stephens R, Mythen M, Kallis P, Davies DWL, Egner W, Rickards A. Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter. Brit J Anaesth. 2001;87:306\u20138.","journal-title":"Brit J Anaesth"},{"key":"269_CR33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/00000542-199811000-00060","volume":"89","author":"E Terazawa","year":"1998","unstructured":"Terazawa E, Shimonaka H, Nagase K, Masue T, Dohi S. Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter. Anesthesiology. 1998;89:1296\u20138.","journal-title":"Anesthesiology"},{"key":"269_CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-127-4-199708150-00001","volume":"127","author":"DG Maki","year":"1997","unstructured":"Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter - a randomized, controlled trial. Ann Intern Med. 1997;127:257\u201366.","journal-title":"Ann Intern Med"},{"key":"269_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199901073400101","volume":"340","author":"RO Darouiche","year":"1999","unstructured":"Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, et al. A comparison of two antimicrobial-impregnated central venous catheters. New Engl J Med. 1999;340:1\u20138.","journal-title":"New Engl J Med"},{"key":"269_CR36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/infdis\/173.2.418","volume":"173","author":"I Raad","year":"1996","unstructured":"Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis. 1996;173:418\u201324.","journal-title":"J Infect Dis"},{"key":"269_CR37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jac\/dkg361","volume":"52","author":"TA Gaonkar","year":"2003","unstructured":"Gaonkar TA, Modak SM. Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model. J Antimicrob Chemother. 2003;52:389\u201396.","journal-title":"J Antimicrob Chemother"},{"key":"269_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jac\/dkl522","volume":"59","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemoth. 2007;59:359\u201369.","journal-title":"J Antimicrob Chemoth."},{"key":"269_CR39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/47.5.589","volume":"47","author":"SM Tambe","year":"2001","unstructured":"Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemoth. 2001;47:589\u201398.","journal-title":"J Antimicrob Chemoth."},{"key":"269_CR40","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/501836","volume":"22","author":"LA Sampath","year":"2001","unstructured":"Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Cont Hosp Ep. 2001;22:640\u20136.","journal-title":"Infect Cont Hosp Ep"},{"key":"269_CR41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mimet.2007.11.010","volume":"72","author":"E Peeters","year":"2008","unstructured":"Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods. 2008;72:157\u201365.","journal-title":"J Microbiol Methods"},{"key":"269_CR42","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/nprot.2008.192","volume":"3","author":"J Chandra","year":"2008","unstructured":"Chandra J, Mukherjee PK, Ghannoum MA. Vitro growth and analysis of Candida biofilms. Nat Protoc. 2008;3:1909\u201324.","journal-title":"Nat Protoc"},{"key":"269_CR43","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1128\/AAC.01622-05","volume":"50","author":"H Hanna","year":"2006","unstructured":"Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, et al. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Ch. 2006;50:3283\u20138.","journal-title":"Antimicrob Agents Ch"},{"key":"269_CR44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2047-2994-1-40","volume":"1","author":"A Novikov","year":"2012","unstructured":"Novikov A, Lam MY, Mermel LA, Casey AL, Elliott TS, Nightingale P. Impact of catheter antimicrobial coating on species-specific risk of catheter colonization: a meta-analysis. Antimicrob Resist In. 2012;1:40.","journal-title":"Antimicrob Resist In"},{"key":"269_CR45","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.05836-11","volume":"56","author":"I Raad","year":"2012","unstructured":"Raad I, Mohamed JA, Reitzel RA, Jiang Y, Raad S, Al Shuaibi M, et al. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi. Antimicrob Agents Chemother. 2012;56:935\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"269_CR46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/jac\/dkh483","volume":"54","author":"N Yucel","year":"2004","unstructured":"Yucel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, et al. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial. J Antimicrob Chemoth. 2004;54:1109\u201315.","journal-title":"J Antimicrob Chemoth"},{"key":"269_CR47","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/592253","volume":"47","author":"L Lorente","year":"2008","unstructured":"Lorente L, Lecuona M, Ramos MJ, Jimenez A, Mora ML, Sierra A. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Clin Infect Dis. 2008;47:1171\u20135.","journal-title":"Clin Infect Dis"}],"container-title":["Antimicrobial Resistance & Infection Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-017-0269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T13:52:51Z","timestamp":1510753971000},"score":1,"resource":{"primary":{"URL":"http:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-017-0269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1186\/s13756-017-0269-x","relation":{},"ISSN":["2047-2994"],"issn-type":[{"type":"electronic","value":"2047-2994"}],"subject":[],"published":{"date-parts":[[2017,11,3]]},"article-number":"110"}}